Conjunctival MALT lymphoma: utility of FDG PET/CT for diagnosis, staging, and evaluation of treatment response.

Détails

Ressource 1Télécharger: BIB_009F834B565E.P001.pdf (1197.45 [Ko])
Etat: Public
Version: de l'auteur
ID Serval
serval:BIB_009F834B565E
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Conjunctival MALT lymphoma: utility of FDG PET/CT for diagnosis, staging, and evaluation of treatment response.
Périodique
Clinical Nuclear Medicine
Auteur(s)
Sallak A., Besson F.L., Pomoni A., Christinat A., Adler M., Aegerter J.P., Nguyen C., de Leval L., Frossard V., Prior J.O.
ISSN
1536-0229 (Electronic)
ISSN-L
0363-9762
Statut éditorial
Publié
Date de publication
2014
Volume
39
Numéro
3
Pages
295-297
Langue
anglais
Notes
Publication types: Journal Article Publication Status: ppublish
Résumé
A 67-year-old woman was referred for staging of a mucosa-associated lymphoid tumor lymphoma involving the left conjunctiva. CT scan had shown paravertebral and pelvic masses, and a breast nodule. FDG PET/CT demonstrated moderately increased uptake in the left ocular conjunctiva and confirmed the paravertebral and pelvic masses and the breast nodule. Moreover, abnormal FDG uptake was shown in 2 breast nodules, the flank, the gluteus maximus, and the gastric cardia. The patient received 6 cycles of rituximab-bendamustine chemotherapy with a complete clinical and metabolic response at the 6-month follow-up PET/CT and remained relapse-free without visual acuity problem after a 36-month follow-up.
Pubmed
Web of science
Création de la notice
11/07/2014 17:15
Dernière modification de la notice
20/08/2019 12:22
Données d'usage